Skip to main content
. Author manuscript; available in PMC: 2014 May 12.
Published in final edited form as: Curr Opin Gastroenterol. 2012 May;28(3):266–272. doi: 10.1097/MOG.0b013e3283523c7e

Table 1.

Percentage of involved ICC cases with CNV gain or loss

Chromosome arm ICC Studies (no) Koo et al. [7] (Korea) Wong et al. [10] (Hong Kong) Lee et al. [8] (Korea) Uhm et al. [9] (Korea) Homayounfar et al. [6] (Germany) Moinzadeh et al. [15] HCC (31 studies)
Cases (no.) 98 5 11 13 33 19 22 785
1p- 28 3 21 37 27
3p- 53 2 38 68
3q- 23 1 23
4p- 36 1 36
4q- 35 4 46 21 32 41 34
5q- 26 1 26
6q- 69 2 46 91
8p- 33 3 31 26 41 38
9p- 40 3 38 26 55
9q- 36 1 36
11p- 23 1 23
11q- 23 1 23
12q- 23 1 23
13q- 45 1 45 26
14q- 43 2 31 55
16q- 0 0 36
17p- 40 3 55 38 26 32
18q- 31 3 38 32 23
19p- 32 1 32
21q- 23 1 23
1p+ 23 1 23
1q+ 40 3 54 24 41 57
2q+ 26 1 26
3q+ 37 2 46 27
5p+ 28 3 27 24 32
5q+ 27 2 31 23
6p+ 0 0 22
7p+ 28 3 27 26 32
7q+ 36 1 36
8p+ 39 1 39
8q+ 45 4 36 54 58 32 47
11q+ 37 2 31 42
12p+ 27 1 27
12q+ 23 1 23
13q+ 45 1 45
15q+ 37 2 38 36
16p+ 36 1 36
17q+ 42 3 38 61 26 22
18p+ 39 1 39
18q+ 27 2 27 26
19q+ 26 1 26
20q+ 45 3 36 31 67
HHS Vulnerability Disclosure